Leveraging extensive experience in the biotech and life sciences sectors, the fund manager has successfully executed numerous investments, totaling over 30 deals across Europe and North America. Their operator-first approach emphasizes collaboration with management teams to drive growth and innovation. With a focus on early-stage companies, they have achieved notable exits that underscore a strategic commitment to value creation. The manager’s data-driven investment style ensures well-informed decisions that align with emerging market trends and technological advancements.